Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward

Bookmark and Share
Published: 6 Oct 2022
Views: 65
Prof Richard Sullivan and Dr André Ilbawi

Prof Richard Sullivan (Kings College London, London, UK) and Dr André Ilbawi (Technical Officer Cancer Control, WHO) discuss the policies regarding ease of access to cancer medicines.

Initially, Dr Ilbawi talks about the issues around the policy aspect of access to cancer medicine and what has changed so far in these initiatives.

He further discusses how the world policy regarding access to essential cancer medicine has adapted to the rapid changes in the cancer treatment world and what infrastructure is available to accommodate the new drugs and trials present.

They discuss the limiting factors that WHO faces in increasing access to cancer medicine and how they can be overcome.

They conclude by talking about the future of cancer care and how accessibility to essential cancer medicine can be further improved.